Cellix Bio is an innovative biopharmaceutical company dedicated to the development of targeted therapies and proprietary molecular therapeutics that enhance one or more of the attributes of approved drugs, such as efficacy, therapeutic index, bioavailability and safety.

Our business model creates value with a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Our mission is to participate in the promise of the biotech industry in a profitable, diversified and lower-risk business than a typical biotech company. Our aspiration is to contribute positively to the healthcare system, and improve the lives of patients around the world. Cellix Bio therapeutic portfolio is focused on diverse therapeutic areas including neurology, dermatology, gastrointestinal, inflammation, metabolic & life style, oncology, ophthalmology and infectious diseases.